Why the study?
Does the widespread use of thrombolytic agents and aspirin reduce 1-year mortality in patients with acute myocardial infarction?
Does the widespread use of thrombolytic agents and aspirin reduce 1-year mortality in patients with acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
The widespread implementation of thrombolysis and aspirin for acute myocardial infarction significantly reduced 1-year mortality in patients under 70 years of age, though overall mortality was not significantly changed.
UNLABELLED: During 1 year of follow-up, we compared the mortality after acute myocardial infarction (AMI) prior to and after the introduction of a more widespread use of thrombolytic agents and aspirin. STUDY PERIOD: Two periods (I = 1986-1987 and II = 1989-1990) were compared. PATIENTS: All patients admitted to the coronary care units at the two city hospitals in the community of Goteborg who fulfilled the criteria for development of AMI participated in the evaluation. RESULTS: The overall 1-year mortality rate was 27% [corrected] during period I and 23% during period II (NS). However, among patients up to 70 years of age, the mortality was reduced from 15 to 11% (p < 0.05), whereas among patients aged over 70 years the mortality remained almost unchanged (34 vs. 35%; NS). CONCLUSION: The introduction of a more widespread use of thrombolytic agents and aspirin has not substantially changed the overall mortality in AMI. However, among younger patients, the mortality appears to have been reduced but not among the elderly.
No takes yet. Share an insight, caveat, or question.
Herlitz et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: